Research

Care at University of Minnesota Children’s Hospital, Fairview combines the best of a children’s hospital and academic medicine.

Within the setting of a family-centered care model, patients have access to the newest medical knowledge delivered by physicians and scientists at the cutting edge of their fields.  One example of this is the University of Minnesota Pediatric Advanced Therapies Program. The Advanced Therapies Program is an integrated clinical and translational research program that provides innovative therapies for pediatric and young adult patients with high-risk cancers. The clinical program incorporates a comprehensive and multidisciplinary approach for patients with metastatic and relapsed cancers.  Program activities include new anti-cancer drugs, autologous stem cell transplantation and chemoprotectants, signal transduction inhibitors, cell cycle inhibitors, biological therapies and immunotherapies.

In addition, faculty at University of Minnesota Children’s Hospital, Fairview are leaders in the long-term follow up of childhood cancer survivors, leukemia therapies, and bone tumor research.